•
Jul 31, 2019

Summit Therapeutics Q2 2019 Earnings Report

Total Revenue
$154K
Previous year: $49.8M
-99.7%
EPS
-$0.04
Previous year: $0.42
-109.5%
Gross Profit
$123K
Cash and Equivalents
$27.2M
Free Cash Flow
$25.9M

Summit Therapeutics

Summit Therapeutics